Visualitza per autor "Burotto, Mauricio"
Ara mostrant els elements 1-1 d 1
-
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma
Geynisman, Daniel M.; Burotto, Mauricio; Porta, Camillo; Suárez Rodríguez, Cristina; Bourlon, Maria T.; Huo, Stephen (Springer, 2022-07)